Orion Biotech Opportunities Corp. Units
ORIAU
ORIAU was delisted on the 25th of April, 2023.
4 hedge funds and large institutions have $15.6M invested in Orion Biotech Opportunities Corp. Units in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $15.7M → $15.6M (-$172K)
33% less funds holding
Funds holding: 6 → 4 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$5.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Gritstone Asset Management
Bethesda,
Maryland
|
-$160K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JP
1
JNE Partners
London,
United Kingdom
| $14.6M | – | – | – |
|
|
SIA
2
Schechter Investment Advisors
Birmingham,
Michigan
| $914K | – | – | – |
|
|
6CM
3
683 Capital Management
New York
| $9.76K | – | – | – |
|
|
CS
4
Clear Street
New York
| $8.3K | +$5.58K | +550 | +183% |
|
|
GAM
5
Gritstone Asset Management
Bethesda,
Maryland
| – | -$160K | -16,338 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$1.24K | -127 | Closed |
|
ORIAU Hedge Fund Activity: Q1 2023 in Review
4 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q1 2023, worth a combined $15.6M — down 1.1% from $15.7M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ORIAU and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Clear Street, adding an estimated $5.58K. The largest seller was Gritstone Asset Management, exiting entirely with an estimated $160K sold.
- 4 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q1 2023, down from 6 in Q4 2022.
- Funds reported $15.6M of Orion Biotech Opportunities Corp. Units stock for Q1 2023, down 1.1% quarter-over-quarter.
- 0 funds opened new Orion Biotech Opportunities Corp. Units positions in Q1 2023 and 2 closed out, a net change of -2 holders.
- The largest Orion Biotech Opportunities Corp. Units buyer in Q1 2023 was Clear Street, an estimated $5.58K added.
- The largest Orion Biotech Opportunities Corp. Units seller in Q1 2023 was Gritstone Asset Management, an estimated $160K sold.
Based on aggregated 13F filings for Q1 2023.